- Vor Bio (NASDAQ:VOR) announced on Thursday the appointment of Sandy Mahatme as Chief Financial Officer and Chief Business Officer, effective July 9, 2025.
- Mahatme joins Vor Bio with more than 30 years of executive leadership experience in the biopharmaceutical industry. He